Onward Medical
Onward Medical NV is a Dutch clinical-stage medical technology company developing therapies to restore movement and function in people with spinal cord injuries. The company develops ARC-EX external neurostimulation systems and ARC-IM implantable pulse generators designed to restore limb function, blood pressure regulation, and trunk stability. Main revenue drivers currently comprise investment capital, clinical research grants, and commercial launch revenues as medical devices obtain regulatory approvals. Onward Medical targets neurosurgery centers, spinal rehabilitation clinics, physical therapists, and spinal cord injury patients across Europe and North America. The company holds a pioneer position in targeted neurostimulation technologies for spinal cord restoration. Headquartered in Eindhoven, Netherlands, Onward Medical NV is listed on Euronext Brussels and Euronext Amsterdam.
3 of the funds FundTelligence covers report a position in Onward Medical.
- Legal name
- Onward Medical NV
- Sector
- Health Care
- Country
- Netherlands
- Funds holding it
- 3
Funds holding Onward Medical
- DNB Fund Future Waves — DNB · 0.48 % (full portfolio disclosed, August 2026)
- DNB Fund Disruptive Opportunities — DNB · 0.11 % (full portfolio disclosed, September 2026)
- SEB Läkemedelsfond — SEB · 0.08 % (full portfolio disclosed, June 2026)